| Literature DB >> 35882889 |
Lisheng Chen1, N Dayanthi Perera1, Athanasios J Karoukis1, Kecia L Feathers1, Robin R Ali1,2, Debra A Thompson1,3, Abigail T Fahim4.
Abstract
The retinal pigment epithelium (RPE) is a polarized monolayer that secretes growth factors and cytokines towards the retina apically and the choroid basolaterally. Numerous RPE secreted proteins have been linked to the pathogenesis of age-related macular degeneration (AMD). The purpose of this study was to determine the differential apical and basolateral secretome of RPE cells, and the effects of oxidative stress on directional secretion of proteins linked to AMD and angiogenesis. Tandem mass tag spectrometry was used to profile proteins in human iPSC-RPE apical and basolateral conditioned media. Changes in secretion after oxidative stress induced by H2O2 or tert-butyl hydroperoxide (tBH) were investigated by ELISA and western analysis. Out of 926 differentially secreted proteins, 890 (96%) were more apical. Oxidative stress altered the secretion of multiple factors implicated in AMD and neovascularization and promoted a pro-angiogenic microenvironment by increasing the secretion of pro-angiogenic molecules (VEGF, PTN, and CRYAB) and decreasing the secretion of anti-angiogenic molecules (PEDF and CFH). Apical secretion was impacted more than basolateral for PEDF, CRYAB and CFH, while basolateral secretion was impacted more for VEGF, which may have implications for choroidal neovascularization. This study lays a foundation for investigations of dysfunctional RPE polarized protein secretion in AMD and other chorioretinal degenerative disorders.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35882889 PMCID: PMC9325713 DOI: 10.1038/s41598-022-16701-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Human iPSC-RPE demonstrates appropriate polarity and differentiation, (A) with melanin pigmentation and cobblestone morphology, (B) and rise in TEER after passage onto Transwell filters. N = 6–65 biologic replicates depending on the time point, no technical replicates. Data points show mean ± SD. (C) RT-PCR of RPE markers in iPSC-RPE 11 weeks post-passage compared to primary adult human RPE and ARPE19 cells at 4 weeks and 8 months post-passage (uncropped images are shown in Supplementary Fig. 3). (D) ICC of iPSC-RPE for ZO-1 at tight junctions, and CD147, Ezrin, and Kir7.1 in the apical membrane. Phalloidin is red and DAPI is blue. Staining is shown both before (control) and after (Post-H2O2) exposure to 800 µM H2O2 for 24 h.
Figure 2Human iPSC-RPE polarized secretome is more apical than basolateral. (A) Volcano plot from data set 2 showing proteins with at least twofold change and p < 0.05, in blue (more basolateral) or red (more apical). N = 4 biologic replicates. The 3 most differentially secreted proteins in both the apical and basolateral compartments, as well as proteins of interest as described in the results section, are labeled by number on the graph: 1. RNF7, 2. TIMP3, 3. UBR, 4. PTPN22, 5. CFI, 6. VEGF, 7. C1QTNF5, 8. PTN, 9. HTRA1, 10. CFH, 11. PEDF, 12. RPL12, 13. HMGN2, 14. CRYAB, 15. PSMA1. (B) Dendrogram from data set 2 showing molecular functions that were differentially represented in apical vs basolateral samples (p < 0.05, adjusted for false discovery rate). Analysis was performed using Advaita Bio ipathwayguide[12,13].
Directional secretion of RPE effector proteins.
| Category | Protein | A/BL |
|---|---|---|
| Growth factors and cytokines | LGALS1 (galectin 1) | 10.0*** |
| MIF (macrophage migration inhibitory factor) | 7.7**** | |
| HDGF (heparin binding growth factor) | 5.3***** | |
| ANXA2 (annexin A2) | 5.3**** | |
| GPI (glucose-6-phosphate isomerase) | 4.9**** | |
| ECM1 (extracellular matrix protein 1) | 4.4*** | |
| IGFALS (insulin like growth factor binding protein acid labile subunit) | 3.4*** | |
| ERBB4 (erb-b2 receptor tyrosine kinase 4) | 3.2* | |
| MFGE8 (milk fat globule EGF and factor V/VIII domain containing) | 3.1*** | |
| FAM3C (FAM3 metabolism regulating signaling molecule C) | 2.4** | |
| Proteases | PSMA1 (proteasome 20S subunit alpha 1) | 26.3**** |
| PSMA5 (proteasome 20S subunit alpha 5) | 17.1***** | |
| PSMA2 (proteasome 20S subunit alpha 2) | 14.6***** | |
| PSMA4 (proteasome 20S subunit alpha 4) | 8.1***** | |
| PEPD (peptidase D) | 6.6**** | |
| LTA4H (leukotriene A4 hydrolase) | 6.4*** | |
| CPQ (carboxypeptidase Q) | 6.0**** | |
| PDIA3 (protein disulfide isomerase family A member 3) | 5.8*** | |
| PRCP (prolylcarboxypeptidase) | 5.2**** | |
| CNDP2 (carnosine dipeptidase 2) | 4.8** | |
| AGA (aspartylglucosaminidase) | 4.7** | |
| PSMD2 (proteasome 26S subunit, non-ATPase 2) | 4.3**** | |
| PSMA7 (proteasome 20S subunit alpha 7) | 4.0***** | |
| PSMA6 (proteasome 20S subunit alpha 6) | 3.8**** | |
| DPP7 (dipeptidyl peptidase 7) | 3.6**** | |
| PSMD7 (proteasome 26S subunit, non-ATPase 7) | 3.5** | |
| CTSV (cathepsin V) | 3.4** | |
| PSMB6 (proteasome 20S subunit beta 6) | 3.4**** | |
| PSMD1 (proteasome 26S subunit, non-ATPase 1) | 3.4** | |
| PSMB3 (proteasome 20S subunit beta 3) | 3.3***** | |
| CTSC (cathepsin C) | 3.2** | |
| GGH (gamma-glutamyl hydrolase) | 3.2*** | |
| PSMB7 (proteasome 20S subunit beta 7) | 3.2**** | |
| PSMB5 (proteasome 20S subunit beta 5) | 3.2**** | |
| Protease inhibitors | CRYAB (crystallin alpha B) | 10.2**** |
| SERPINB9 (serpin family B member 9) | 6.7** | |
| CSTB (cystatin B) | 5.7***** | |
| SERPINE3 (serpin family E member 3) | 4.2** | |
| SERPINF2 (serpin family F member 2) | 3.2** | |
| SERPINE1 (serpin family E member 1) | 3.0** | |
| Extracellular matrix | COL14A1 (collagen type XIV alpha 1 chain) | 5.1** |
| COL6A2 (collagen type VI alpha 2 chain) | 4.2*** | |
| COL6A1 (collagen type VI alpha 1 chain) | 3.8*** | |
| CHI3L1 (chitinase 3 like 1) | 3.5** | |
| COL11A1 (collagen type XI alpha 1 chain) | 3.3** | |
| TGFBI (transforming growth factor beta induced) | 3.2* | |
| Complement cascade | CD81 (CD81 molecule) | 6.3** |
| HSP90AB1 (heat shock protein 90 alpha family class B member 1) | 4.8*** | |
| Lipid homeostasis | FABP3 (fatty acid binding protein 3) | 4.6*** |
| ANGPTL4 (angiopoietin like 4) | 3.5**** | |
A/BL = apical to basolateral ratio; proteins are listed from highest to lowest A/BL within each category. Due to size constraints, only proteins with at least threefold difference between apical and basolateral are shown. Bold highlights proteins with more basolateral than apical secretion. P-values were calculated with a two-tailed student’s T-test with a Benjamin-Hochberg adjustment. P-value < 0.05 (*), < 0.01 (**), < 0.001 (***), < 0.0001 (****), or < 0.00001 (*****).
RPE directional secretion of proteins encoded by disease genes.
| Disease | Protein | A/BL |
|---|---|---|
| Oculocutaneous albinism (OCA) | TYRP1 | 3.7** |
| Tay-Sachs | HEXA | 3.4*** |
| Stickler syndrome | COL11A1 | 3.3** |
| Stickler syndrome | COL9A2 | 2.4** |
| Cone-rod dystrophy | CDHR1 | 2.0** |
| Retinitis pigmentosa (RP) | SNRNP200 | 2.0** |
| Late onset retinal degeneration (LORD) | C1QTNF5 | 1.0 |
| Doyne honeycomb macular dystrophy | ||
| Cone-rod dystrophy | ||
| Microphthalmia; retinal dystrophy, iris coloboma, and comedogenic acne syndrome | ||
| Sorsby macular dystrophy | ||
| Congenital cataract | CRYAB | 10.2**** |
| Mucopolysaccharidosis type IV (with corneal clouding) | GLB1 | 7.5*** |
| Primary open angle glaucoma (POAG) | OPTN | 5.3** |
| Congenital Cataract | VIM | 4.4*** |
| Corneal dystrophies | TGFBI | 3.2* |
| Amyloidosis, meretoja syndrome; lattice corneal dystrophy | GSN | 2.0* |
| Gaucher disease (with corneal opacities) | GBA | 2.0* |
| Microphthalmia | ALDH1A3 | 5.4*** |
| Progressive external ophthalmoplegia | RRM2B | 4.8*** |
| Age-related macular degeneration risk loci | C3 | 1.5* |
| FBLN5 | 1.3 | |
| CFH | 1.3 | |
| HTRA1 | 1.2 | |
A/BL = apical to basolateral ratio; proteins are listed from highest to lowest A/BL within each category. Bold highlights proteins with more basolateral than apical secretion. P-values were calculated with a two-tailed student’s T-test with a Benjamin-Hochberg adjustment. P-value < 0.05 (*), < 0.01 (**), < 0.001 (***), < 0.0001 (****), or > 0.05 (non-significant, no asterisk).
RPE directional secretion of angiogenic factors.
| Protein | A/BL |
|---|---|
| CRYAB (crystallin alpha B) | 10.2**** |
| ANXA3 (annexin A3) | 7.7*** |
| ECM1 (extracellular matrix protein 1) | 4.4*** |
| ANGPTL4 (angiopoietin like 4) | 3.5**** |
| ANXA1 (annexin A1) | 3.5*** |
| SERPINE1 (serpin family E member 1) | 3.0** |
| GRN (granulin precursor) | 2.8*** |
| MYDGF (myeloid derived growth factor) | 2.7** |
| SFRP1 (secreted frizzled related protein 1) | 0.8 |
| VEGFA (vascular endothelial growth factor A) | 0.7 |
| PGK1 (phosphoglycerate kinase 1) | 7.1***** |
| TGFBI (transforming growth factor beta induced) | 3.2* |
| SERPINF1 (serpin family F member 1; aka PEDF) | 2.9** |
| COL4A2 (collagen type IV alpha 2 chain) | 2.5*** |
| NAXE (NAD(P)HX epimerase) | 2.1** |
| FN1 (fibronectin 1) | 1.8** |
| THBS1 (thrombospondin 1) | 1.4 |
| PTN (pleiotrophin) | 1.2 |
| TGFB2 (transforming growth factor beta 2) | 0.8 |
A/BL = apical to basolateral ratio; proteins are listed from highest to lowest A/BL within each category. Bold highlights proteins with more basolateral than apical secretion. P-values were calculated with a two-tailed student’s T-test with a Benjamin-Hochberg adjustment. P-value < 0.05 (*), < 0.01 (**), < 0.001 (***), < 0.0001 (****), or > 0.05 (non-significant, no asterisk).
Figure 3Reactive Oxygen Species (ROS) production after oxidative stress in iPSC-RPE. Graph shows relative fluorescence detection after iPSC-RPE are exposed to either 800 µM H2O2 or 1 mM tBH, with or without pre-treatment with 400 µM quercetin, using Carboxy-H2DCFDA as a fluorescent cell-permeant indicator of ROS. For the H2O2 experiments, n = 12 for the H2O2 group and n = 6 for the control group and the H2O2 + quercetin group. For the tBH experiments, n = 5 for all groups. All replicates were biologic; there were no technical replicates. Results were analyzed by Kruskal–Wallis for the H2O2 experiments due to unequal sample size, and by one-way ANOVA for the tBH experiments. *p < 0.05, ****p < 0.0001, ns = not significant.
Figure 4H2O2-induced oxidative stress alters RPE polarized secretion of angiogenic regulatory factors. Bar graphs show differences in apical and basolateral secretion of VEGF, PEDF, CFH, and PTN before (Pre-treatment, black) and after incubation with (A) 800 µM H2O2 for 24 h (Post-H2O2, light grey), or (B) 1 mM tBH for 6 h (Post-tBH, light grey). Dark grey bars show protective effects of quercetin pre-treatment prior to oxidative stress with H2O2 or tBH. N = 9. Results were analyzed by paired 2-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns = not significant. There was no significant interaction between polarity and treatment effects for PTN, but p-values for post-hoc comparisons are still shown.
Figure 5H2O2- and tBH-induced oxidative stress increase RPE polarized CRYAB secretion. Western blot shows CRYAB in apical and basolateral conditioned media before (PRE) and after (POST) incubation with (A) 800 µM H2O2 for 24 h, or (B) 1 mM tBH for 6 h, with or without pre-treatment with quercetin. As there is no endogenous protein suitable for normalization between apical and basolateral samples, equal amounts of recoverin (RCVRN) were spiked into samples and used as controls. N = 3. Cropped blots are shown. Uncropped images are in Supplementary Fig. 4.